Search Results 1311-1320 of 18717 for Relapse

  1. Oncology (Medical) - Clinical trials

    Additionally, no studies to date have investigated this during intralesional tumor resections. NL-201 in Patients With Relapsed or Refractory Cancer. Rochester, ...

  2. Oncology (Medical) - Clinical trials

    ... Relapsed Or Refractory Chronic Lymphocytic Leukemia. Rochester, Minn. This study will assess the safety, tolerability, pharmaokinetics, and preliminary ...

  3. Publications - Kristen B. McCullough, Pharm.D., R.Ph. - Mayo Clinic

    Molecular predictors of response and survival in patients with relapsed/refractory acute myeloid leukemia following venetoclax plus hypomethylating agent ...

  4. Teclistamab-cqyv (subcutaneous route) - Side effects & uses - Mayo Clinic

    Teclistamab-cqyv injection is used to treat relapsed (cancer that has come back) or refractory (cancer that did not respond to treatment) multiple myeloma ...

  5. Oncology (Medical) - Clinical trials

    Additionally, no studies to date have investigated this during intralesional tumor resections. NL-201 in Patients With Relapsed or Refractory Cancer. Rochester, ...

  6. Publications - Javier L. Munoz, M.D., M.B.A. - Mayo Clinic

    ... relapsed/refractory non-Hodgkin lymphoma: A multicenter consensus approach. Am J Hematol. 2024 Jan; 99 (1):124-134 Epub 2023 Nov 11. View PubMed; Gaulin C ...

  7. T Cell Lymphoma Clinical Trials - Mayo Clinic Research

    This phase II trial studies how well giving ruxolitinib phosphate (oral JAK inhibitor INCB18424) works in treating patients with relapsed or refractory ...

  8. Cocaine hydrochloride (nasal route) - Side effects & uses - Mayo Clinic

    Cocaine hydrochloride nasal solution is used to numb the mucous membrane inside the nose before a medical procedure or surgery. This medicine is a local ...

  9. Treating pediatric patients with primary and recurrent rhabdomyosarcoma - Mayo Clinic

    ... , Mayo Clinic treats pediatric patients with primary and recurrent rhabdomyosarcoma, offering a cutting-edge treatment option for relapsed disease.

  10. Publications - Patrick B. Johnston, M.D., Ph.D. - Mayo Clinic

    ... Relapsed/Refractory Non-Hodgkin Lymphoma. Clin Lymphoma Myeloma Leuk ... Incidence of Central Nervous System Relapse in Primary Mediastinal Large B ...